Blog

Enrique Soto: Proposals for the design, analysis, and reporting of Phase 3 RCTs in oncology

Enrique Soto/X

Feb 12, 2025, 08:12

Enrique Soto: Proposals for the design, analysis, and reporting of Phase 3 RCTs in oncology

Enrique Soto, Geriatric oncologist and Editor-in-Chief of ecancer’s journal, shared an article he and colleagues authored on X:

“Want an entertaining, thought-provoking read to start the week? Take a look at our Common Sense Oncology proposals for the design, analysis, and reporting of Phase 3 RCTs in oncology. We would love to hear your thoughts!!!”

Common Sense Oncology principles for the design, analysis, and reporting of phase 3 randomised clinical trials

Authors: Bishal Gyawali et al.

enrique soto

Aaron M Goodman Bernard L. Marini Bishal Gyawali Brooke E. Wilson cancer Christopher M. Booth Dario Trapani Elizabeth A. Eisenhauer Enrique Soto Pérez Enrique Soto Perez de Celis Ghulam Rehman Mohyuddin Gregory R Pond Ian F. Tannock Madeline L Pe Manju Sengar Michelle Tregear Nathan I Cherny OncoDaily Oncology Rachel Koven Winette van der Graaf

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology

Leo Messi, Richard Gere and Alejandra, Princess Dina and Paco Arango join the Global OncoThon to support childhood cancer research